FDA Looks Into Alli and Xenical Liver Damage Concerns
New research shows concern that two popular weight loss drugs, Alli and Xenical, may cause liver damage. On Monday, August 24, 2009, the Food and Drug Administration (FDA) began investigating recent reports that these drugs may be causing liver damage in those who take them.
To date, there have been 30 reported cases of liver damage by those who take Alli, the only non-prescription weight loss drug the FDA has approved, and Xenical, its prescription counterpart. Of the 30 reports, 27 individuals have been hospitalized and six of them have experienced liver failure.
Both drugs are marketed by British drugmaker GlaxoSmithKline PLC, but Xenical is manufactured by pharmaceutical giant Roche. 





